ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs MXN
16.87959
-0.61%
Brent Oil
83.475
0.42%
Bitcoin
63,178.56
-1.28%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Genvec, Inc. (GNVC)

  7. Genvec, Inc. (GNVC) Noticias

GNVC

Genvec, Inc. (GNVC)

Genvec, Inc.
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GNVC
FechaHoraFuenteTítuloSímboloCompañía
26/06/201715:17Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:GNVCGenvec, Inc.
20/06/201715:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNVCGenvec, Inc.
16/06/201710:08Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNVCGenvec, Inc.
16/06/201709:34Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:GNVCGenvec, Inc.
16/06/201709:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNVCGenvec, Inc.
16/06/201708:15PR Newswire (US)Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec AcquisitionNASDAQ:GNVCGenvec, Inc.
16/06/201708:09Edgar (US Regulatory)(25-NSE)NASDAQ:GNVCGenvec, Inc.
12/05/201715:37Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:GNVCGenvec, Inc.
10/05/201715:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GNVCGenvec, Inc.
23/04/201718:35PR Newswire (US)Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of GenVec, Inc. - GNVCNASDAQ:GNVCGenvec, Inc.
14/03/201716:29Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GNVCGenvec, Inc.
14/03/201715:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNVCGenvec, Inc.
06/03/201715:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GNVCGenvec, Inc.
01/03/201716:10PR Newswire (US)Intrexon Announces Fourth Quarter and Full Year 2016 Financial ResultsNASDAQ:GNVCGenvec, Inc.
16/02/201715:37Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GNVCGenvec, Inc.
08/02/201717:56PR Newswire (US)WeissLaw LLP: GenVec, Inc. Acquisition May Not Be in the Best Interests of GNVC ShareholdersNASDAQ:GNVCGenvec, Inc.
24/01/201715:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GNVCGenvec, Inc.
24/01/201715:07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GNVCGenvec, Inc.
24/01/201708:00PR Newswire (US)Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery PlatformNASDAQ:GNVCGenvec, Inc.
11/01/201707:00PR Newswire (US)GenVec to Present at Phacilitate Cell & Gene Therapy World 2017NASDAQ:GNVCGenvec, Inc.
01/12/201606:00PR Newswire (US)GenVec Effects 1-for-10 Reverse Stock SplitNASDAQ:GNVCGenvec, Inc.
04/11/201606:30PR Newswire (US)GenVec Reports Third Quarter 2016 Financial ResultsNASDAQ:GNVCGenvec, Inc.
28/09/201607:00PR Newswire (US)GenVec To Present At 2016 Cell & Gene Meeting On The MesaNASDAQ:GNVCGenvec, Inc.
12/09/201611:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GNVCGenvec, Inc.
02/09/201615:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:GNVCGenvec, Inc.
26/08/201615:16Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GNVCGenvec, Inc.
05/08/201606:30PR Newswire (US)GenVec Reports Second Quarter 2016 Financial ResultsNASDAQ:GNVCGenvec, Inc.
25/07/201606:30PR Newswire (US)FDA Lifts Clinical Hold On CGF166NASDAQ:GNVCGenvec, Inc.
12/05/201607:00PR Newswire (US)GenVec Reports First Quarter 2016 Financial ResultsNASDAQ:GNVCGenvec, Inc.
06/05/201616:57Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GNVCGenvec, Inc.
 Showing the most relevant articles for your search:NASDAQ:GNVC

Su Consulta Reciente

USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
NYSE
VZ
Verizon Communications
NASDAQ
NVDA
NVIDIA
NYSE
CVX
Chevron
NASDAQ
AAPL
Apple
NYSE
AXP
American Express
AMEX
XLE
Energy Select Sector SPDR
SPI
SP500
S&P 500
USOTC
BASFY
BASF (QX)
FX
EURMXN
Euro vs MXN
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
NASDAQ
TSLA
Tesla
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados